AzTrials
AzTrials

Physical ActivityFit4TwoNCT04527731

Physical Activity Level During Pregnancy

An observational study of Physical Activity and Well-being, run by University Medicine Greifswald at 1 site in Germany.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

This study examines (1) the extent and intensity of physical activity among women in different phases of their pregnancy and (2) the relationship between patterns of physical activity in pregnancy and well-being. Read more about this study

Who is it for?
Ages 18 years and older, women onlyHealthy volunteers can take part
Conditions the study is for
Physical Activity, Well-being
What is being tested?
Accelerometry
Type of treatment
Medical device
How many people
36 participants
Where
1 siteGermany
Study dates
25 Feb 2020to 30 May 2022
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • Women only
  • Healthy volunteers accepted
  • Adult, Older adult

Study population: Convenience Sample (female only)

Who may be able to join

  • current pregnancy, until pregnancy week 23

Who cannot join

  • cognitive impairment
  • insufficient language skills

Trial locations and contacts

1 site in 1 country.

Germany1 site
  • University Medicine Greifswald

    Greifswald, 17475

Other trials in Germany

About this study

Official title: Fit for Two - A Pilot Study on Physical Activity Levels During Pregnancy

This study examines (1) the extent and intensity of physical activity among women in different phases of their pregnancy and (2) the relationship between patterns of physical activity in pregnancy and well-being.

Read the detailed description

This study examines physical activity in different phases of pregnancy using accelerometry. The recruitment of pregnant women (N=30) in the first or second trimester (until week 23) will be realized over different channels (e.g, local newspapers, facebook, and leaflets in gynecological practices, shopping centers, and nurseries).

Informed consent consists of: (i) activity recording over seven consecutive days using an accelerometer, (ii) completion of standardized questionnaires, (iii) participation in a cardiac ultrasound examination in the German Center for Cardiovascular Research (DZHK) - examination center.

Participants are asked to wear an accelerometer at daytime, and over seven consecutive days, in trimester 1 (week 9-12), trimester 2 (week 23-26), and trimester 3 (week 36-39). Women who are attended the study in the first trimester wear the device up to three time whereas those who are attended the study in their second trimester wear the device up to twice. At the end of each measurement period women are invited to fill in a self-administered questionnaire. Also they are invited to participate in a cardiac ultrasound examination. Optionally, participants may receive feedback on their physical activity measured by accelerometer as well as about results of cardiac ultrasound examination upon completion of the study.

Being tested
Accelerometry
Keywords
Pregnancy, Physical activity, Accelerometry
Medical subject headings
Motor Activity

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • AccelerometryDevice

    Participants are asked to wear an accelerometer during the day for a period of seven days.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Extent and intensity of physical activity between pregnancy week 9 and 12

    Assessement via accelerometry

    Measured: between pregnancy week 9 and 12

  2. Extent and intensity of physical activity between pregnancy week 23 and 26

    Assessement via accelerometry

    Measured: between pregnancy week 23 and 26

  3. Extent and intensity of physical activity between pregnancy week 36 and 39

    Assessement via accelerometry

    Measured: between pregnancy week 36 and 39

Secondary outcomes (13)
  1. Well-being

    Assessement via self-administered questionnaire: The World Health Organisation- Five Well-Being Index (WHO-5),The total raw score, ranging from 0 to 25, is multiplied by 4 to give the final score, with 0 representing the worst imaginable well-being and 100 representing the best imaginable well-being.

    Measured: between pregnancy week 9 and 12

  2. Well-being

    Assessement via self-administered questionnaire: The World Health Organisation- Five Well-Being Index (WHO-5),The total raw score, ranging from 0 to 25, is multiplied by 4 to give the final score, with 0 representing the worst imaginable well-being and 100 representing the best imaginable well-being.

    Measured: between pregnancy week 23 and 26

  3. Well-being

    Assessement via self-administered questionnaire: The World Health Organisation- Five Well-Being Index (WHO-5),The total raw score, ranging from 0 to 25, is multiplied by 4 to give the final score, with 0 representing the worst imaginable well-being and 100 representing the best imaginable well-being.

    Measured: between pregnancy week 36 and 39

  4. Mother-child bond

    Assessement via self-administered questionnaire: Maternal Antenatal Attachment Scale (MAAS) consists of 19 items which are scored 1-5, with higher scores indicating higher levels of bonding.

    Measured: between pregnancy week 9 and 12

  5. Mother-child bond

    Assessement via self-administered questionnaire: Maternal Antenatal Attachment Scale (MAAS) consists of 19 items which are scored 1-5, with higher scores indicating higher levels of bonding.

    Measured: between pregnancy week 23 and 26

  6. Mother-child bond

    assessement via self-administered questionnaire: Maternal Antenatal Attachment Scale (MAAS) consists of 19 items which are scored 1-5, with higher scores indicating higher levels of bonding.

    Measured: between pregnancy week 36 and 39

  7. Sociodemographics

    age, education (</=/> school years), partnership, employment status

    Measured: between pregnancy week 9 and 12

  8. Left ventricular muscle mass index

    Echocardiography will be done by qualified staff.

    Measured: Echocardiography between pregnancy week 9 and 12

  9. Left ventricular muscle mass index

    Echocardiography will be done by qualified staff.

    Measured: cardiac ultrasound measurement between pregnancy week 23 and 26

  10. Left ventricular muscle mass index

    Echocardiography will be done by qualified staff.

    Measured: Echocardiography between pregnancy week 36 and 39

  11. Echocardiographic global strain, in %

    Echocardiography will be done by qualified staff.

    Measured: Echocardiography between pregnancy week 9 and 12

  12. Echocardiographic global strain, in %

    The cardiac ultrasound examination will be conduced by qualified staff.

    Measured: cardiac ultrasound measurement between pregnancy week 23 and 26

  13. Echocardiographic global strain, in %

    Echocardiography will be done by qualified staff.

    Measured: Echocardiography between pregnancy week 36 and 39

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted26 Aug 2020
  2. Study start25 Feb 2020
  3. Primary completion30 May 2022
  4. Study completion30 May 2022

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
36 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04527731
Sponsor's protocol ID
BB002/20
Acronym
Fit4Two
Status last verified
Dec 2023
First submitted
17 Jun 2020
Last updated
8 Dec 2023
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

An observational study of Physical Activity and Well-being, run by University Medicine Greifswald at 1 site in Germany.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 8 Dec 2023. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Germany. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Extent and intensity of physical activity between pregnancy week 9 and 12 (time frame: between pregnancy week 9 and 12). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 8 Dec 2023; AzTrials last refreshed its copy on 29 Oct 2026.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in